Navigation Links
Intercell Supports the Japanese Encephalitis Vaccination Recommendations of CDC's Advisory Committee on Immunization Practices
Date:6/24/2009

ctive immunization of adults against the Japanese Encephalitis virus. The total development time for this vaccine was more than 10 years. The vaccine was developed under a Collaborative Research and Development Agreement with the Walter Reed Army Institute of Research, a biomedical research laboratory for the U.S. Department of Defense.

Intercell's Phase III trials for IXIARO found that the vaccine demonstrated immunogenicity against Japanese Encephalitis and an overall clinical safety profile similar to the control arm, combined with an excellent local tolerability profile. These data were published in The Lancet in December 2007:

  • The immunogenicity was comparable to that of the U.S. licensed product, JE-VAX(R).
  • Intercell's vaccine demonstrated an overall clinical safety profile similar to the control arm.
  • Further, Intercell's Japanese Encephalitis vaccine had a more favorable local tolerability profile in the head-to-head study with JE-VAX(R).

About Intercell AG

Intercell AG is an innovative biotechnology company that develops novel vaccines for the prevention and treatment of infectious diseases with substantial unmet medical needs. Intercell's vaccine to prevent Japanese Encephalitis is the Company's first product on the market.

The Company's technology platforms include an antigen-discovery system, adjuvants and a novel patch-based delivery system (Vaccine Patch, Vaccine Enhancement Patch). Based on these technologies, Intercell has strategic partnerships with a number of global pharmaceutical companies, including Novartis, Merck & Co., Inc., Wyeth, and Sanofi Pasteur.

The Company's pipeline includes a Travelers' Diarrhea Vaccine Patch (Phase III in preparation), a Pseudomonas vaccine candidate (Phase II), a Vaccine Enhancement Patch to prevent Pandemic Influenza in c
'/>"/>

SOURCE Intercell AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Intercell to Webcast Research & Development Day on Thursday, June 4, 2009
2. Intercell Executes Multi-Year Contract for Supply of IXIARO(R) to the United States Military
3. Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis
4. Helicobacter pylori inhibits intercellular communication of cultured gastric cells
5. Greenway Medical Technologies Supports Community-Based Interoperability Efforts by Offering Preferred Rates to Buffalo, N.Y. Area Community Healthcare Organizations
6. Satellite Healthcare Supports Kidney Wellness in Chicago
7. Lifeclinic Supports Healthy Workforce and Health Promotion First Acts
8. Lifeclinic Supports Healthy Workforce and Health Promotion First Acts
9. Zysolin(TM) Pre-clinical Data Supports Once-a-day Dosing in Humans
10. American College of Surgeons Supports Bill to Create New Frontline Providers Loan Repayment Program
11. Study supports validity of test that indicates widespread unconscious bias
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... (PRWEB) September 20, 2014 Final Cut ... announced the release of the Information theme for FCPX filmmakers. ... use to describe the Information theme,” says Christina Austin, CEO ... to look so professional.” , Information features easy to use ... parameters of the environment. Change the background color, color of ...
(Date:9/20/2014)... MarijuanaDoctors.com recently returned to New ... PAIN Week conference that was held at the ... Las Vegas from September 2nd to September 6th. ... in the hopes of educating physicians in regards ... tool to treat chronic Pain, MarijuanaDoctors.com accomplished goals ...
(Date:9/19/2014)... 19, 2014 “Copay coupons,” a drug ... brand drugs among patients with prescription drug coverage, may ... a new report from the Department of Health ... Federal anti-kickback laws prohibit suppliers from offering side-payments to ... federal government. , The report highlights that two recent ...
(Date:9/19/2014)... 2014 (HealthDay News) -- As kids transition from elementary ... cyberbullies, according to a recent study. But ... 8 found that verbal and physical bullying declines as ... intervention and prevention strategies must address all types of ... and girls, the researchers said. The study was published ...
(Date:9/19/2014)... with The Melanoma Genetics Consortium, GenoMEL, an international research ... Journal of the National Cancer Institute that proves ... the first time, we have established that the genes ... in the risk of developing melanoma," said lead author ... at the University of Leeds (UK). , Telomeres ...
Breaking Medicine News(10 mins):Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2Health News:MarijuanaDoctors.com Experiences Unprecedented Support and Growth at Pain Week 2014 2Health News:PCMA: New OIG Report Cites Drug Manufacturer“Copay Coupon” Use in Medicare Part D 2Health News: Cyberbullying Seems to Ramp Up in Middle School 2Health News:Melanoma risk found to have genetic determinant 2
... Customers to Contribute $5 to Support,the American Red ... The Wireless Foundation,and the American Red Cross ... can make a charitable donation to the Red ... program. Here,s how it works:,Subscribers of participating wireless ...
... launch a new series in the ... field of cancer research., ... exclusive XM Satellite broadcast to health care,professionals of Stand Up To ... ReachMD XM 157 joins the,major TV networks of ABC, CBS and ...
... Entertainment to State,s Largest Hospice ... ... LodgeNet,Healthcare, a division of LodgeNet Interactive Corporation (Nasdaq: LNET ),today ... Patient Television System to the state,s first,hospice program, St. Francis Hospice ...
... reluctance to prescribe antidepressants, study suggests , , TUESDAY, Sept. 2 ... on the rise after a 15-year decline, and the trend ... a new study suggests. , Researchers thought a spike in ... the new study found the increase in suicides continued during ...
... Chapel Hill researchers have demonstrated that a drug called ... and hospital admissions in children with acute gastroenteritis. , ... that causes vomiting and diarrhea. It is often popularly ... in children during the winter months. , "Children under ...
... says , , TUESDAY, Sept. 2 (HealthDay News) -- ... and cancer risk, but it also suggests that ... The results of a small study published recently ... of developing cancer. In that study, called SEAS, ...
Cached Medicine News:Health News:Wireless Subscribers Can Text 2HELP the American Red Cross 2Health News:Wireless Subscribers Can Text 2HELP the American Red Cross 3Health News:ReachMD XM 157 to Present Stand Up To Cancer Special as the Only Live Simulcast on XM Satellite Radio for Health Care Professionals 2Health News:ReachMD XM 157 to Present Stand Up To Cancer Special as the Only Live Simulcast on XM Satellite Radio for Health Care Professionals 3Health News:LodgeNet Healthcare Expands Into Hawaii Through Agreement With St. Francis Hospice 2Health News:LodgeNet Healthcare Expands Into Hawaii Through Agreement With St. Francis Hospice 3Health News:Youth Suicides Continue to Rise in U.S. 2Health News:Youth Suicides Continue to Rise in U.S. 3Health News:Ondansetron reduces vomiting, hospital admissions in children with gastroenteritis 2Health News:No Definitive Link Seen Between Vytorin and Cancer 2Health News:No Definitive Link Seen Between Vytorin and Cancer 3
(Date:9/19/2014)... LUBBOCK, Texas , Sept. 19, 2014 Kiromic, ... today the addition of Kent Hance , the former ... vice chairman. Hance retired as chancellor in July 2014, after ... pleased to announce that Kent Hance , the most ... joined the Kiromic team not only as an investor, but ...
(Date:9/19/2014)... RESEARCH TRIANGLE PARK, N.C. , Sept. 19, ... company focused on cloud-based drug design and development, ... strategy. The company,s mission is to design new ... Phase 1 and 2 partners to further their ... enhance its portfolio investments. To support this business ...
(Date:9/19/2014)... , Sept. 19, 2014 Merck (NYSE: MRK ... and Canada , is teaming with celebrity ... Diabetes: Logra Tus Metas , an educational program encouraging Hispanics with ... -- a key treatment goal to help reduce the risk of ... are at a higher risk for developing type 2 diabetes ...
Breaking Medicine Technology:Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5
... chain, has revealed that one in four* (24%) of the population ... or applied medicines which they later discovered were out of date. ... people do not always check the expiry date of medicines before ... This is worrying considering that nearly one in six people ...
... A major new study presented today at the yearly ... in New Orleans shows conclusively that replacing defective aortic ... than through much more invasive open-heart surgery – leads ... trial study ( PARTNER cohort A: Transcatheter valves noninferior ...
Cached Medicine Technology:Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 2Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 3Major New Study Shows Aortic Valve Replacement Via Catheter Produces Better Outcomes Than Traditional Open-Heart Surgery 2Major New Study Shows Aortic Valve Replacement Via Catheter Produces Better Outcomes Than Traditional Open-Heart Surgery 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: